Literature DB >> 27721032

Timing Is Everything: Combining Post-Transplantation Adoptive Cell Therapy and Tumor Vaccines.

Miguel-Angel Perales1.   

Abstract

Entities:  

Keywords:  Dendritic cell; Donor lymphocyte infusion; Vaccine

Mesh：

Substances：

Year:  2016        PMID： 27721032      PMCID： PMC5568660          DOI： 10.1016/j.bbmt.2016.10.002

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  22 in total

Review 1.  Fast Cars and No Brakes: Autologous Stem Cell Transplantation as a Platform for Novel Immunotherapies.

Authors:  Miguel-Angel Perales; Craig S Sauter; Philippe Armand
Journal:  Biol Blood Marrow Transplant       Date:  2015-10-17       Impact factor: 5.742

2.  Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse.

Authors:  Nirali N Shah; David M Loeb; Hahn Khuu; David Stroncek; Tolu Ariyo; Mark Raffeld; Cindy Delbrook; Crystal L Mackall; Alan S Wayne; Terry J Fry
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-12       Impact factor: 5.742

3.  Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus.

Authors:  J F Morris; S L Madden; O E Tournay; D M Cook; V P Sukhatme; F J Rauscher
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

4.  Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation.

Authors:  Marlise R Luskin; Martin Carroll; David Lieberman; Jennifer J D Morrissette; Jianhua Zhao; Lisa Crisalli; David B Roth; Selina M Luger; David L Porter; Ran Reshef
Journal:  Biol Blood Marrow Transplant       Date:  2016-07-28       Impact factor: 5.742

5.  WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell-depleted hematopoietic stem cell transplantation and donor lymphocyte infusions.

Authors:  Eleanor M Tyler; Achim A Jungbluth; Richard J O'Reilly; Guenther Koehne
Journal:  Blood       Date:  2012-11-16       Impact factor: 22.113

6.  Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1.

Authors:  Emanuela Romano; Jesse W Cotari; Rosa Barreira da Silva; Brian C Betts; David J Chung; Francesca Avogadri; Mitsu J Fink; Erin T St Angelo; Babak Mehrara; Glenn Heller; Christian Münz; Gregoire Altan-Bonnet; James W Young
Journal:  Blood       Date:  2012-04-17       Impact factor: 22.113

7.  Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1.

Authors:  Tao Dao; Dmitry Pankov; Andrew Scott; Tatyana Korontsvit; Victoriya Zakhaleva; Yiyang Xu; Jingyi Xiang; Su Yan; Manuel Direito de Morais Guerreiro; Nicholas Veomett; Leonid Dubrovsky; Michael Curcio; Ekaterina Doubrovina; Vladimir Ponomarev; Cheng Liu; Richard J O'Reilly; David A Scheinberg
Journal:  Nat Biotechnol       Date:  2015-09-21       Impact factor: 54.908

8.  Targeting the intracellular WT1 oncogene product with a therapeutic human antibody.

Authors:  Tao Dao; Su Yan; Nicholas Veomett; Dmitry Pankov; Liang Zhou; Tatyana Korontsvit; Andrew Scott; Joseph Whitten; Peter Maslak; Emily Casey; Taochao Tan; Hong Liu; Victoria Zakhaleva; Michael Curcio; Ekaterina Doubrovina; Richard J O'Reilly; Cheng Liu; David A Scheinberg
Journal:  Sci Transl Med       Date:  2013-03-13       Impact factor: 17.956

9.  Expression of the Wilms' tumor gene (WT1) in human leukemias.

Authors:  H Miwa; M Beran; G F Saunders
Journal:  Leukemia       Date:  1992-05       Impact factor: 11.528

10.  Enhanced responses to tumor immunization following total body irradiation are time-dependent.

Authors:  Adi Diab; Robert R Jenq; Gabrielle A Rizzuto; Adam D Cohen; Deonka W Huggins; Taha Merghoub; Manuel E Engelhorn; José A Guevara-Patiño; David Suh; Vanessa M Hubbard-Lucey; Adam A Kochman; Suzie Chen; Hong Zhong; Jedd D Wolchok; Marcel R M van den Brink; Alan N Houghton; Miguel-Angel Perales
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.